Medical Marijuana 2010: It's Time to Fix the Regulatory Vacuum
- 1 September 2010
- journal article
- Published by Cambridge University Press (CUP) in The Journal of Law, Medicine & Ethics
- Vol. 38 (3), 654-666
- https://doi.org/10.1111/j.1748-720x.2010.00519.x
Abstract
Washington, D.C.’s City Council has recently taken the first step towards legalizing the use of “medical marijuana” in accordance with the provisions of the Legalization of Marijuana for Medical Treatment Initiative of 1998 (Initiative 59). This action was not overruled by the United States Congress within the 30-day deadline imposed by the District of Columbia’s Home Rule Statute. The Council is now crafting regulations that will govern the therapeutic and palliative use of this drug with the goal of avoiding some of the problems faced by the other states that have legalized medical marijuana; however, the proposed rules do not establish criteria for legitimate medical practice when medical marijuana is recommended (discussed infra). If the enabling regulations are passed by the D.C. Council and not rejected by the Congress, the District of Columbia will join over onequarter of the states in legalizing medical marijuana (Table I). On the other hand, if the D.C. Council fails to act favorably on the final regulations (or if Congress nullifies the Council’s approval), then the effective legalization of medical marijuana will die and not be reconsidered until next year.Keywords
This publication has 9 references indexed in Scilit:
- Medical Marijuana and the LawNew England Journal of Medicine, 2010
- On the Limits of Supremacy: Medical Marijuana and the States' Overlooked Power to Legalize Federal CrimeSSRN Electronic Journal, 2009
- Survey of intrathecal opioid usage in the UKEuropean Journal of Anaesthesiology, 2008
- Escalation of Drug Use in Early-Onset Cannabis Users vs Co-twin ControlsPublished by American Medical Association (AMA) ,2003
- Does Marijuana Use Cause the Use of Other Drugs?JAMA, 2003
- Placebo-Controlled Trials and Active-Control Trials in the Evaluation of New Treatments. Part 1: Ethical and Scientific IssuesAnnals of Internal Medicine, 2000
- Federal Regualtions for the Prescription of Controlled SubstancesPublished by Springer Science and Business Media LLC ,1999
- Reefer Madness — The Federal Response to California's Medical-Marijuana LawNew England Journal of Medicine, 1997
- Marijuana, the AIDS Wasting Syndrome, and the U.S. GovernmentNew England Journal of Medicine, 1995